Healthcare provider profile · identity verified

Priya Sadhu, MD

Family Practice · SAINT CHARLES, MO · NPI 1275864712

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	639	195
Amlodipine Besylate	Amlodipine Besylate	352	99
Lisinopril	Lisinopril	346	98
Levothyroxine Sodium	Levothyroxine Sodium	221	63
Alprazolam	Alprazolam	204	49
Pantoprazole Sodium	Pantoprazole Sodium	197	56
Hydrochlorothiazide	Hydrochlorothiazide	180	51
Losartan Potassium	Losartan Potassium	164	47
Metoprolol Succinate	Metoprolol Succinate	157	45
Metformin Hcl	Metformin Hcl	156	47
Gabapentin	Gabapentin	155	55
Omeprazole	Omeprazole	153	45
Rosuvastatin Calcium	Rosuvastatin Calcium	131	41
Simvastatin	Simvastatin	128	37
Alendronate Sodium	Alendronate Sodium	127	43
Meloxicam	Meloxicam	126	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	37
Trazodone Hcl	Trazodone Hcl	96	33
Arexvy	Rsvpref3 Antigen/As01e/Pf	95	95
Sertraline Hcl	Sertraline Hcl	95	29
Pravastatin Sodium	Pravastatin Sodium	93	30
Metformin Hcl Er	Metformin Hcl	92	30
Escitalopram Oxalate	Escitalopram Oxalate	89	25
Furosemide	Furosemide	89	27
Metoprolol Tartrate	Metoprolol Tartrate	85	25
Clopidogrel	Clopidogrel Bisulfate	70	25
Albuterol Sulfate Hfa	Albuterol Sulfate	65	34
Citalopram Hbr	Citalopram Hydrobromide	64	15
Duloxetine Hcl	Duloxetine Hcl	63	14
Tramadol Hcl	Tramadol Hcl	63	27
Atenolol	Atenolol	58	19
Tamsulosin Hcl	Tamsulosin Hcl	58	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	16
Fluticasone Propionate	Fluticasone Propionate	52	24
Allopurinol	Allopurinol	51	15
Bupropion Xl	Bupropion Hcl	50	15
Jardiance	Empagliflozin	49	13
Glipizide	Glipizide	48	14
Amitriptyline Hcl	Amitriptyline Hcl	45	14
Diazepam	Diazepam	44	suppressed
Ezetimibe	Ezetimibe	44	15
Montelukast Sodium	Montelukast Sodium	43	14
Famotidine	Famotidine	42	14
Spironolactone	Spironolactone	40	suppressed
Eliquis	Apixaban	39	suppressed
Ozempic	Semaglutide	38	16
Pioglitazone Hcl	Pioglitazone Hcl	37	16
Tizanidine Hcl	Tizanidine Hcl	37	15
Lorazepam	Lorazepam	36	15
Farxiga	Dapagliflozin Propanediol	35	suppressed
Clonazepam	Clonazepam	34	suppressed
Glipizide Er	Glipizide	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Mounjaro	Tirzepatide	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	17
Fluoxetine Hcl	Fluoxetine Hcl	33	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	17
Celecoxib	Celecoxib	31	13
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	16
Donepezil Hcl	Donepezil Hcl	28	suppressed
Ondansetron Odt	Ondansetron	28	suppressed
Finasteride	Finasteride	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	12
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Nystatin	Nystatin	21	11
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Prednisone	Prednisone	18	14
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Topiramate	Topiramate	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Glimepiride	Glimepiride	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Metronidazole	Metronidazole	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Fluconazole	Fluconazole	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Temazepam	Temazepam	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Methylprednisolone	Methylprednisolone	13	12
Amoxicillin	Amoxicillin	12	11
Azelastine Hcl	Azelastine Hcl	12	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	12	suppressed
Digoxin	Digoxin	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Linzess	Linaclotide	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error